Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

MapLight Therapeutics, Inc. (MPLT)

NASDAQ

$11,98

$--

(0,00%)

Pre-Market

MapLight Therapeutics, Inc. (MPLT) Live Price Chart

Last updated: ⁦2026-09-16 09:46:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

MapLight Therapeutics, Inc. (MPLT) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $11,98, with a market capitalisation of $609,87M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $9,10 to $40,43. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$609,87M
Open	$11,98
Day's High	$40,43
Day's Low	$9,10
Previous Close	$12,08
Volume	12,00
Average Volume	878,41K
P/E Ratio	--
52-Week High	$40,43
52-Week Low	$9,10
Dividend Yield	--
Earnings Date	--

MapLight Therapeutics, Inc. (MPLT) Pre-Market Stock Price

MapLight Therapeutics, Inc. (MPLT) is trading at $11,98 in pre-market trading as of 2026-09-16 08:02:00, down 0,83% ($0,10) from the previous close of $12,08

Pre-market trading shows how investors are pricing MPLT before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

MapLight Therapeutics, Inc. (MPLT) 7-Day Stock Price Change

Over the past seven days, MapLight Therapeutics, Inc. (MPLT) moved from $13,77 to $11,98, representing a decline of 13,00% ($1,79).

The stock traded between $11,98 and $14,22 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 447,72 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

MPLT 52-Week Price Position

Position in Range: 9,2%

52W Low$9,10

52W High$40,43

MPLT is currently trading at $11,98, placing it 9,2% of the way from its 52-week low of $9,10 to its 52-week high of $40,43. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is MapLight Therapeutics, Inc. (MPLT)?

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

MapLight Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	133
Exchange	NASDAQ
Company Website	https://www.maplightrx.com

How to Buy MapLight Therapeutics, Inc. (MPLT) Stock on MEXC

Eligible investors can buy real shares of MapLight Therapeutics, Inc. (MPLT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for MPLT and Place Your Order

Open the RealStocks trading page and search for MPLT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is MapLight Therapeutics, Inc. (MPLT) stock price today?

MapLight Therapeutics, Inc. (MPLT) is currently trading at $ 11,98, down 0,83% ($0,10) from the previous close of $ 12,08. Intraday prices update in real time during regular trading hours.

2.Is MPLT stock going up or down today?

As of 2026-09-16 08:02:00, MPLT is trading at $ 11,98, down 0,83% ($0,10) from its previous close of $ 12,08. The stock has traded between $ 9,10 and $ 40,43 during today’s regular session. Past price movements do not guarantee future results.

3.What is MPLT pre-market price?

As of 2026-09-16 08:02:00, MPLT is trading at $ 11,98 in pre-market trading, down 0,83% ($0,10) from the previous close of $ 12,08. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is MPLT after-hours price?

As of 2026-09-16 08:02:00, MPLT is trading at $ 11,98 in after-hours trading, down 0,83% ($0,10) from the regular-session close of $ 12,08. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is MPLT stock trading now?

MPLT trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does MPLT sit relative to its 52-week high and low?

Over the past 52 weeks, MPLT has traded between a low of $ 9,10 and a high of $ 40,43. At $ 11,98, the stock is positioned 9,2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is MapLight Therapeutics, Inc. in?

MapLight Therapeutics, Inc. (MPLT) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is MapLight Therapeutics, Inc.'s market capitalisation and where is it listed?

MapLight Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 609,87M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is MPLT valued in terms of P/E ratio and EPS?

MPLT trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -4,96. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does MapLight Therapeutics, Inc. pay a dividend?

MapLight Therapeutics, Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.